toluene hydrochloride | 22658-38-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: toluene hydrochloride
• 英文别名: toluene; compound with hydrogen chloride；Toluol; Verbindung mit Chlorwasserstoff；HCl toluene；toluene;hydrochloride
• CAS: 22658-38-4
• 化学式: C₇H₈*ClH
• 分子量: 128.601
• InChiKey: RLUJQBLWUQZMDG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.42
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  0
• 氢给体数：
  1
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  度洛西汀 、 toluene hydrochloride 在 甲苯 作用下， 以 甲苯 为溶剂， 以until a pH of 3 was obtained的产率得到盐酸度洛西汀
  参考文献：
  名称：

  Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof

  摘要：

  提供制备DNT基、度洛西汀烷基氨基甲酸酯、度洛西汀基和度洛西汀盐酸盐的工艺。同时，提供将DNT基、度洛西汀烷基氨基甲酸酯和度洛西汀基转化为药学上可接受的度洛西汀盐酸盐的工艺。

  公开号：

  US20060194869A1
• 作为试剂：
  描述：

  1,4-二羟基蒽醌 在 toluene hydrochloride 、 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 6.5h， 生成 4-morpholino-9,10-dioxo-4a,9,9a,10-tetrahydroanthracen-1-yl 4-methylbenzenesulfonate
  参考文献：
  名称：

  Anthracene-9, 10-dione derivatives induced apoptosis in human cervical cancer cell line (CaSki) by interfering with HPV E6 expression

  摘要：

  A new series of anthracene-9, 10-dione derivatives have been synthesized to increase cytotoxic activity against human papillomavirus (HPV) positive cancer cell line, CaSki. The highest cytotoxicity was achieved by 4-(benzylamino)-9,10-dioxo-4a,9,9a,10-tetrahydroanthracen-1-y1 4-ethylbenzenesulfonate (5) with the inhibitory concentration 50 (IC50) of 0.3 mu M which is 20 times lower than that of cisplatin (CDDP; IC50 = 8.0 mu M). The toxicity against non-cancerous cell line, WI-38, was low with the IC50 > 10 mu M. Treatment with this compound resulted in decreasing HPV E6 expression. Furthermore, increasing p53 and decreasing Bcl-2 expression were noted. Cell cycle profiles revealed an accumulation of cells in the G2/M phase. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.02.006

文献信息

• Process for the preparation of 10-methoxycarbamazepine
  申请人：——

  公开号：US20030105076A1

  公开（公告）日：2003-06-05

  A process for the preparation of 10-methoxycarbamazepine, an important intermediate in the preparation of 10-oxo-10, 11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide(oxcarbazepine) from 10-methoxy-5H-dibenz(b,f)azepine(10-methoxyiminostilbene), is disclosed, which process comprises reacting 10-methoxyiminostilbene with cyanic acid (HOCN) in the presence of a mild acidic reagent in a solvent. Also disclosed is an improved method for the hydrolysis of 10-methoxycarbamazepine to oxcarbazepine, which method comprises carrying out the hydrolysis in a biphasic system chosen such that the oxcarbazepine is substantially insoluble in both phases, whereas the by-products or impurities are soluble in at least one of the phases. The oxcarbazepine thereby prepared is an anticonvulsant, and has been proposed for use as an anti-epileptical agent in the treatment of AIDS-related neural disorders, and for the treatment of Parkinson's disease and/or Parkinsonian syndromes.

  一种制备10-甲氧卡马西平的方法被披露，该方法是从10-甲氧基-5H-二苯并(b,f)氮杂环庚-5-甲酰胺(奥卡西平)的制备中间体10-氧代-10,11-二氢-5H-二苯并(b,f)氮杂环庚-5-甲酰胺(奥卡西平)开始的，该方法包括在溶剂中，在温和酸性试剂的存在下，将10-甲氧基亚胺基蒽与氰酸(HOCN)反应。还披露了一种改进的方法，用于将10-甲氧卡马西平水解为奥卡西平，该方法包括在选择的两相系统中进行水解，使得奥卡西平在两相中均基本不溶解，而副产物或杂质在至少一相中可溶解。因此制备的奥卡西平是一种抗癫痫药物，并已被提议用于治疗艾滋病相关的神经疾病，并用于帕金森病和/或帕金森综合征的治疗。
• METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME
  申请人：TAKASAGO INTERNATIONAL CORPORATION

  公开号：US20180057447A1

  公开（公告）日：2018-03-01

  The purpose of the present invention is to provide a cooling agent composition containing a novel methyl menthol derivative having no undesirable feeling of stimulation, malodor, bitterness, or the like, it being possible to use the cooling agent composition as a cooling agent or sensory stimulation agent having exceptional persistence of a sense of coolness and refreshing feeling. The present invention pertains to a cooling agent composition containing a methyl menthol derivative represented by general formula (1A) or general formula (1B).

  本发明的目的是提供一种冷却剂组合物，其中包含一种新型的甲基薄荷醇衍生物，不具有刺激感、恶臭、苦味等不良感觉，可以将该冷却剂组合物用作具有出色持久感觉的凉爽和清新感的冷却剂或感官刺激剂。本发明涉及一种含有由通式（1A）或通式（1B）表示的甲基薄荷醇衍生物的冷却剂组合物。
• Azulene derivatives and salts thereof
  申请人：Tomiyama Hiroshi

  公开号：US20050124555A1

  公开（公告）日：2005-06-09

  The present invention provides an azulene derivative and a salt thereof, wherein an azulene ring is bonded to a benzene ring directly or via a lower alkylene which may be substituted with a halogen atom and the benzene ring is directly bonded to the glucose residue, and it is usable as a Na + -glucose cotransporter inhibitor, especially for a therapeutic and/or preventive agent for diabetes such as insulin-dependent diabetes (type 1 diabetes) and insulin-independent diabetes (type 2 diabetes), as well as diabetes-related diseases such as insulin-resistant diseases and obesity.

  本发明提供了一种吲哚蓝衍生物及其盐，其中吲哚蓝环直接或通过可被取代为卤原子的较低烷基与苯环结合，苯环直接与葡萄糖残基结合，可用作Na+-葡萄糖共转运蛋白抑制剂，特别用于治疗和/或预防糖尿病，如胰岛素依赖型糖尿病（1型糖尿病）和胰岛素非依赖型糖尿病（2型糖尿病），以及糖尿病相关疾病，如胰岛素抵抗性疾病和肥胖症。
• PROCESS FOR THE PREPARATION OF OPTICALLY PURE FESOTERODINE DERIVATIVES
  申请人：CRYSTAL PHARMA, S.A.U.

  公开号：US20150094485A1

  公开（公告）日：2015-04-02

  3,3-diphenylpropylamines of general formula (I), particularly Fesoterodine, as well as their enantiomers, solvates and salts, can be produced by treating a compound of formula (II) with a chiral alcohol to yield the diastereomeric esters of formula (IV) and (IV′), which can be further transformed into a compound of formula (I), or an enantiomer, solvate or salt thereof, wherein R1 is C1-C8 alkyl; and R2 and R3, independently of one another, represent H or C1-C6 alkyl, or together form a ring of 3 to 7 members with the nitrogen to which they are bound.

  一般式（I）的3,3-二苯基丙基胺，特别是费索特罗定（Fesoterodine），以及它们的对映体、溶剂合物和盐类，可以通过用手性醇处理一种具有式（II）的化合物来生产，以得到式（IV）和（IV'）的对映异构酯，然后可以进一步转化为具有式（I）的化合物，或其对映体、溶剂合物或盐类，其中R1为C1-C8烷基；R2和R3分别表示H或C1-C6烷基，或者一起形成一个由3到7个成员组成的环，与它们结合的氮原子。
• NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND
  申请人：TAKASAGO INTERNATIONAL CORPORATION

  公开号：US20210047283A1

  公开（公告）日：2021-02-18

  A lactone compound is represented by general formula (A), and an ether compound is represented by general formula (B). In formula (A), R is a hydrogen atom or R1. When R is a hydrogen atom, R′ is R1, the carbon bond (1) is a single bond or a double bond, and the carbon bond (2) is a single bond. When R is R1, R′ is a hydrogen atom or R1, both the carbon bonds (1) and (2) are a single bond, or one of them is a double bond and the other is a single bond. In formula (B), R″ is R1. R1 represents a specific alkyl group, a specific alkenyl group, a specific alkynyl group, or an aryl group. In formulas (A) and (B), n is 0 or 1.

  一种内酯化合物由通式（A）表示，一种醚化合物由通式（B）表示。在通式（A）中，R是氢原子或R1。当R是氢原子时，R′是R1，碳键（1）是单键或双键，碳键（2）是单键。当R是R1时，R′是氢原子或R1，碳键（1）和（2）都是单键，或其中一个是双键，另一个是单键。在通式（B）中，R″是R1。R1代表一个特定的烷基基团，一个特定的烯基基团，一个特定的炔基基团或芳基。在通式（A）和（B）中，n为0或1。